ARTICLE | Clinical News
Dimebon: Phase II data
July 21, 2008 7:00 AM UTC
Researchers published previously reported data in The Lancet showing that Dimebon met the primary and secondary endpoints of ADAS-Cog and clinician interviews, respectively, in a placebo-controlled, d...